P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 209 500 KRW -4.34% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PharmaResearch Co Ltd
Total Liabilities & Equity Peer Comparison

Comparables:
068270
302440
H
145020
N
007390
196170

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Total Liabilities & Equity
â‚©601.5B
CAGR 3-Years
21%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Total Liabilities & Equity
â‚©19.9T
CAGR 3-Years
56%
CAGR 5-Years
40%
CAGR 10-Years
24%
SK Bioscience Co Ltd
KRX:302440
Total Liabilities & Equity
â‚©1.9T
CAGR 3-Years
49%
CAGR 5-Years
36%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Total Liabilities & Equity
â‚©899.4B
CAGR 3-Years
-3%
CAGR 5-Years
0%
CAGR 10-Years
N/A
N
NatureCell Co Ltd
KOSDAQ:007390
Total Liabilities & Equity
â‚©71.8B
CAGR 3-Years
-2%
CAGR 5-Years
7%
CAGR 10-Years
12%
Alteogen Inc
KOSDAQ:196170
Total Liabilities & Equity
â‚©306.3B
CAGR 3-Years
6%
CAGR 5-Years
33%
CAGR 10-Years
N/A

See Also

What is PharmaResearch Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
601.5B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Total Liabilities & Equity amounts to 601.5B KRW.

What is PharmaResearch Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
18%

Over the last year, the Total Liabilities & Equity growth was 19%. The average annual Total Liabilities & Equity growth rates for PharmaResearch Co Ltd have been 21% over the past three years , 18% over the past five years .

Back to Top